{"name":"Gan & Lee Pharmaceuticals.","slug":"gan-lee-pharmaceuticals","ticker":"","exchange":"","domain":"ganlee.com","description":"Gan & Lee Pharmaceuticals is a biopharmaceutical company focused on the research, development, and commercialization of innovative drugs, particularly in the areas of diabetes and other metabolic diseases. The company has a robust pipeline with 13 drugs in various stages of development, including several in Phase 1 trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Bempedoic Acid Tablet","genericName":"Bempedoic Acid Tablet","slug":"bempedoic-acid-tablet","indication":"Chronic gout management and hyperuricemia","status":"phase_3"},{"name":"Dupilumab Injection","genericName":"Dupilumab Injection","slug":"dupilumab-injection","indication":"Other","status":"marketed"},{"name":"GZR18 injection A","genericName":"GZR18 injection A","slug":"gzr18-injection-a","indication":"Other","status":"phase_1"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"GZR18","genericName":"GZR18","slug":"gzr18","indication":"Type 1 diabetes mellitus","status":"phase_3"},{"name":"Semaglutide(Wegovy® )","genericName":"Semaglutide(Wegovy® )","slug":"semaglutide-wegovy","indication":"Chronic weight management in adults with obesity or overweight with at least one weight-related condition","status":"phase_3"}]}],"pipeline":[{"name":"Bempedoic Acid Tablet","genericName":"Bempedoic Acid Tablet","slug":"bempedoic-acid-tablet","phase":"phase_3","mechanism":"Bempedoic acid inhibits AMPK-activated protein kinase to reduce uric acid production and lower serum uric acid levels.","indications":["Chronic gout management and hyperuricemia","Gout prophylaxis in patients intolerant to or inadequately controlled by conventional urate-lowering therapy"],"catalyst":""},{"name":"Dupilumab Injection","genericName":"Dupilumab Injection","slug":"dupilumab-injection","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"GZR18","genericName":"GZR18","slug":"gzr18","phase":"phase_3","mechanism":"GZR18 is a long-acting basal insulin analog designed to provide sustained glucose control in diabetes.","indications":["Type 1 diabetes mellitus","Type 2 diabetes mellitus"],"catalyst":""},{"name":"GZR18 injection A","genericName":"GZR18 injection A","slug":"gzr18-injection-a","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Semaglutide(Wegovy® )","genericName":"Semaglutide(Wegovy® )","slug":"semaglutide-wegovy","phase":"phase_3","mechanism":"Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics the action of the natural hormone GLP-1 to regulate blood sugar levels.","indications":["Chronic weight management in adults with obesity or overweight with at least one weight-related condition","Treatment of type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQN1ZrS1NxNXV6cG16bHpTR09LdHNuZW02aVhyWmpNRFV4N3FISmxwM0hWbzFGeTVpeXhZZWc5NU9kVVh1TkVMYnlkRTA3QjdqNXRlMUdzSFBqc0Y1b1pxXy1vV2R2LTRnNmJVY21nd3hQRFZlZHpLWVhHcTJkYTh0Q05PdjlQN3J4Z2g2S0xiODNUUlRzVGh6cUFZZlhtU19QcFV5ZnhOcmlRWUFsZzZMdjFVd2hFazJDOHlpZWZwUmNRZw?oc=5","date":"2026-04-01","type":"trial","source":"BioPharma APAC","summary":"Gan And Lee Pharmaceuticals Reports Phase 3 Success For Once Weekly Insulin GZR4 - BioPharma APAC","headline":"Gan And Lee Pharmaceuticals Reports Phase 3 Success For Once Weekly Insulin GZR4","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxQVmxYQjJQTk9ILXZtVXRwbkl2N01MSUIwM0lPa3lfS0M0N29NeklWNUpKR2NndGVqZzBOUTZVcWxaU184ZHdXZVVaRXFCSTN2dExsRC1lcXE4SFlieVRCc1VnaTdMQ094dlpjMWtkUlNxczFKbVl5VW91T192R2U2ZTZTUTVvY3FiaDdJNVBmeWJDUDhLNGVuM0pZbkJBbHBxb1BRUDVSWVFIWjZic3libmdycmVYTk1WRjQ3dmw0LUF5WTBRRm5DX2dJU0ZZUTFINTR1YWFnV3c2aGNVYnBvaUFKN19idw?oc=5","date":"2026-01-20","type":"pipeline","source":"هيئة الدواء المصرية","summary":"EDA Chairman Discusses Localization of the Pharmaceutical Industry with Gyptho Pharma and China’s Gan & Lee - هيئة الدواء المصرية","headline":"EDA Chairman Discusses Localization of the Pharmaceutical Industry with Gyptho Pharma and China’s Gan & Lee - هيئة الدوا","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNcTB4YW1Rek9DQmUwWFZDc3B2b2FsOGs4SnE5YWhFdWpIUENXTUtoVG5WbGhtZURINk1iYVUySXptRVFzZFJicEM4eG82eHZvZW1OQmJ2eW5ZZUU0ZEYySnhpbERHTExoZzlTc0phVm1tdzBLYkdxRFhQdnhkektjZ1AtUW5kRGFjMXZ1SFQzZzFURWNzZkN2MVVMdUd2U294T0xkdjZR?oc=5","date":"2025-12-31","type":"deal","source":"The Pharma Letter","summary":"Lupin signs exclusive GLP-1 licensing deal with Gan & Lee - The Pharma Letter","headline":"Lupin signs exclusive GLP-1 licensing deal with Gan & Lee","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxPQy1wZ3RaVF93b1VaOXJOSlJscnQyVjdza1k1QXRVVHVMV0JXM29sX0xFOUFmdUdvWW5sUmxGQzNGdXhUNkVoN0h3OGdxbWtHbFVXdTYzM2o3dDU2Vjc5dnd3S210R3JycFlSQ2h1dGMyRU9wWVVsdTBXT3Z2dHVzVm0wMzNyRk1kVHV2ODFLbFRQNlBFWnRGRVVPOFZuVnd5a3RKNFhFQ3pCT2ZHdmFqaThid01raVBEa2FjT3pNbmJRM1FScFFKeHVZVFJyWGJPU1AtSnhReFh2YjFWYks4VTVn0gHnAUFVX3lxTFBONG1ERTdmUEJEVVg0QTQyelBSSDc2UEtIOE01WDRSY1NIRDBDNTVXUjlUdldfaXdGUVQtdmdrY0JCY2UtRk45a3N5TGpReGxUQWVHVW9jY0lXaUlXUC1wSXVDSUZVS2d5ZG5JbXUwd3hlbXhrX0pmRjQzcmp2TGc5NW5DU0hTa1lrYjByZ05UTHVVRG5MU002MDZMYXZqdHljNXJuWXl3Skgta2F1N0pYUHBybGdPQThROUtsVm5oVHNvMGJPVjFsN3RsWTBhSVhxck43a2pyWXQ3blEyd3B3YmJCWUs3MA?oc=5","date":"2025-12-30","type":"deal","source":"ET Pharma","summary":"Lupin in-licenses fortnightly weight-loss drug from China’s Gan & Lee Pharma - ET Pharma","headline":"Lupin in-licenses fortnightly weight-loss drug from China’s Gan & Lee Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOYWNVaHViak9uWml1UnJBRmJJREkyRUZ0ajk2RWVOdmtMeDF4X0NEbnhoQXZCOWN6SXQ2cDBHT2dyaDhXWW5ESWxKT1VFRlhST1UxSl9zd0FuQzZZNmc0UTJzV2lRLXlucDR3SnMxaGdpU3NYZDhZRFg1YUhJdEN4RE4teXZWc1JVcHFtT2ZnMHpQQmcyV1FXcGFLcTdhWmpxT1HSAacBQVVfeXFMTXR6SW5IQ0VnR1hBUktXVEJ3enZjdDYxdHMyeWxFTXV3Z3VleWZsZ1FOTy1LaWtJN1NDQ3hGNlhqOXI4VzZPVGhmdnRmN3dudXJES0k3dkp4eHVvY0l0VEkzbmhGb0sydG04VVJ3M1ZuRUszZ2JrV3drWl84QW1qaWpuTzhNbE04V19nTHctT1FIM2otcEVhd3Y0SjhIeFFpVG16YmEwMTg?oc=5","date":"2025-12-30","type":"pipeline","source":"Express Pharma","summary":"Lupin signs exclusive agreement with Gan & Lee for Bofanglutide in India - Express Pharma","headline":"Lupin signs exclusive agreement with Gan & Lee for Bofanglutide in India","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-30","type":"pipeline","source":"medicaldialogues.in","summary":"Lupin signs licensing pact with Gan & Lee Pharma for GLP-1 receptor agonist Bofanglutide - medicaldialogues.in","headline":"Lupin signs licensing pact with Gan & Lee Pharma for GLP-1 receptor agonist Bofanglutide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxQUFBEcF9WNkRibEVHMWdqSHNZajViNWdCUXU1U3hQTk9QMG5aLTlfUVNjVzcxcVBuX2N2ZllBcGZfRzlHa2VzUmE3S0NGX196SkNQMXRzcTE5aVI0Y0xIWHFIYTVWNkNBdWRkR2dKajgzcGJrVE54UGg1YUJKV0RoTmZBSW5saFl6Znd3M01Cb1BFT1BucTdRQ3Q1Y29nYzFHcXc2aDJvRkRfdGVXOUZYc1NDMjFiZkxxNWQyV2d6NHIxLUJuQl9pR0xmNnR1SlJiOHZWd2YxQjExLTQ?oc=5","date":"2025-12-30","type":"pipeline","source":"Dalal Street Investment Journal","summary":"Global Pharma Major-Lupin Signs Agreement with Gan & Lee Pharmaceuticals for Novel GLP-1 Receptor Agonist - Dalal Street Investment Journal","headline":"Global Pharma Major-Lupin Signs Agreement with Gan & Lee Pharmaceuticals for Novel GLP-1 Receptor Agonist","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxQVHdjS0tYY3MyT29XaWRNYjMtVTJGbDkwVmVycmx6VGh4Y3Y2cEZOTTdON180RlFzeU1jckZRQl9PcnR4QTlnbzcxbG5jVG9nUWxjZkRYaFJydkxzRmZKU0FTTHhFdVhCTlNWNmgyYjhtWExKb2huczBJZUQtSjlXVklIZDJ0eHZDam80MGhtMzZfVkMzZ3JiNHVvR0NsNlJqQjdqaTJSLV93OFNnUmt6VTNEZDZRZ0tvLThfMjM4YzVVYUFhTDNGcDVUQjBUc2ZJRWZ5ZXRYWUVpV0hqWFZJ?oc=5","date":"2025-12-29","type":"pipeline","source":"lupin.com","summary":"Lupin Signs Exclusive Licensing Agreement with Gan & Lee Pharmaceuticals for novel GLP-1 receptor agonist - lupin.com","headline":"Lupin Signs Exclusive Licensing Agreement with Gan & Lee Pharmaceuticals for novel GLP-1 receptor agonist","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNajBVVGREQm1pRHhSc3BGUzdEeDRzaEF4SWtfdWc5SkRqWDd0WFZtQk9tLXViLUdoQ3pIQnM1dld6ZFZycGRtVWxpZTZzWmVKUXdWVDJYM0tNOVJnQWMzSjdUSzVYeEtTTWRwUjQ4M2FQc1RmNHI0ZlJVc0c2ejZwWl9kTUNnSnZaY1JqNUo2RkdDY3hfejdwSVNqWE3SAaIBQVVfeXFMUC1pUldUZlcxUkpubjFtMTVyLWIyUzlNOUstUVl2RHRTVVJsemN4WlI3ZXFPSWk1Tm1qSlpLRzRzRmNySTRJMWpkaE4xSFhCekRlYUFRTnRRRGdPYlVxbUNDNXhwM05NUWpSaEdLNXEwdHNJTW96M3g2SUJqWnJjbW9hOTdmR2dLVnJPU0g0eGd2VU5pR1IyYnFONVdnd1duRkpn?oc=5","date":"2025-12-29","type":"pipeline","source":"Rediff MoneyWiz","summary":"Lupin & Gan Lee Pact for Obesity Drug in India - Rediff MoneyWiz","headline":"Lupin & Gan Lee Pact for Obesity Drug in India","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPaUJwVGc4Nzd0Ry16b2MtYU1nOTdyZnNwMVM2Zjl6T0lrS1dmZUhZMzk2alZXRGFHWi1CVnZzdUdTWGNQSnhTd21vU3VRMFprc1ZFOVFiMlYyelZzb051azE1cTFNZ09NTFBGb3M1Tmo3Yk1SNzUxNTJ4OThrX0JsUXR2N2NKVWczLWxuaHVOY1RaWG11Tm5BdjF6cU1vcVRrRFFaTGpPRmgwMC1EaF9rOERiSkxBMmxGMU5UNUFMSmd3Z9IByAFBVV95cUxQY1FnX0pBeGR2emdMZGMzamM0dC1lQVlVY3VJUlJhdllRZFBLYk92RFJuWmxIUk5wYXh5cTM0SFFZOTRaV3E0RTVvakRnMDRvZDN5cEY4aHFpXzRYZG5PUmR1Y2MxSXNiUnVDTDZvQzk4OG13M0xGOFQ4cFREa2RnbDFvOGdWVVJEREVGcGw0cE5lcXhWRHZUWmktd2hGT0dqR0FBMEJudkJYWkhPVlhON3E4RHRkX0RPaVN0Rmo3anJVZHVlZWxKcg?oc=5","date":"2025-11-30","type":"trial","source":"Indian Pharma Post","summary":"Gan & Lee Pharma launches Phase 3 trial of once-monthly weight-loss jab - Indian Pharma Post","headline":"Gan & Lee Pharma launches Phase 3 trial of once-monthly weight-loss jab","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFB1Ul9NcllDbFdhS3BPODRoV0FNYmJpU0l5Y2NTRklDLTRGbUNuX2IyaE5IelRmRlAxcy1ObDMtYW9NTTEyeHZhSWRhZ0cwMHo0S0h3?oc=5","date":"2025-11-27","type":"trial","source":"FirstWord Pharma","summary":"Gan & Lee starts Phase III study in China for once-monthly GLP-1 shot - FirstWord Pharma","headline":"Gan & Lee starts Phase III study in China for once-monthly GLP-1 shot","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwJBVV95cUxNZmJLZmhibU9hNllhaXpoMGtYZEpJOWFhaVRRcEQyTkRUZ191ZVVwNUF4M2FKbkVuTlBFSE11a2ctUkVrdEZPUEFMb09RWUxzWjdWa2JTZVotYkxvQzh1STJTOE9FUHFhSHVabzlYNFIyd1VfRjZYX3BGZ2lma1N1Ym5HYmcwa3p6Z2J1YmJPQTFNVmwwVDFPRlpfczd2UmdVMlZLNlNvYzQtYVZmVzVVMThMOFNWbXJ6aXpfWGlWd1JhVmhGcGJDTGFvamFaa2VWemZ3N3ExMEozQVdVWXJPbi1XR3BtdmtMS0FnVmVBVDRzc19tZklFcG9LUlA5QVRSR1pvOU4zQUg4cUxObEUtMFdkTVdZd1ljN09xcEVMaUttUFFOSXE3Um1obw?oc=5","date":"2024-06-17","type":"trial","source":"PR Newswire","summary":"Gan & Lee Pharmaceuticals to Present Groundbreaking Data on Three Innovative Products at the American Diabetes Association's 84th Scientific Sessions - PR Newswire","headline":"Gan & Lee Pharmaceuticals to Present Groundbreaking Data on Three Innovative Products at the American Diabetes Associati","sentiment":"neutral"}],"patents":[],"drugCount":5,"phaseCounts":{"phase_3":3,"marketed":1,"phase_1":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}